Shah J، Kent Shellenberger، Daniel M. Canafax (15 يونيو 2002) [1972]. "Zonisamide". Antiepileptic Drugs (ط. Fifth). Philadelphia: Lippincott Williams & Wilkins. ص. 873. ISBN:0-7817-2321-3. اطلع عليه بتاريخ 2007-11-07.
Iwata, Y؛ Irie, S؛ Uchida, H؛ Suzuki, T؛ Watanabe, K؛ Iwashita, S؛ Mimura, M (15 أبريل 2012). "Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial". Journal of the Neurological Sciences. ج. 315 ع. 1–2: 137–140. DOI:10.1016/j.jns.2011.12.010. PMID:22285275.
Gadde، Kishore M.؛ Franciscy، Deborah M.؛ Wagner, II، H. Ryan؛ Krishnan، K. Ranga R. (أبريل 2003). "Zonisamide for Weight Loss in Obese Adults: A Randomized Controlled Trial". Journal of the American Medical Association. ج. 289 ع. 14: 1820–1825. DOI:10.1001/jama.289.14.1820. PMID:12684361.
Hasegawa، Hisanori (مايو 2004). "utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital". Curr Med Research Opinion. ج. 20 ع. 5: 577–580. DOI:10.1185/030079904125003313. PMID:15140322.
Leppik، Ilo E. (ديسمبر 2004). "Zonisamide: chemistry, mechanism of action, and pharmacokinetics". Seizure. ج. 13 ع. Suppl 1: S5–9, discussion S10. DOI:10.1016/j.seizure.2004.04.016. PMID:15511691.
Ueda، Y؛ Doi، T؛ Tokumaru، J؛ Willmore، J (19 أغسطس 2003). "Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures". Molecular Brain Research. ج. 116 ع. 1–2: 1–6. DOI:10.1016/S0169-328X(03)00183-9. PMID:12941455.
Ohmori، S.؛ Nakasa H؛ Asanome K؛ Kurose Y؛ Ishii I؛ Hosokawa M؛ Kitada M (8 مايو 1998). "Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells". Biochimica et Biophysica Acta. ج. 1380 ع. 3: 297–304. DOI:10.1016/s0304-4165(97)00156-6. PMID:9555064.
Stiff، D. D.؛ Robicheau JT؛ Zemaitis MA. (يناير 1992). "Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative". Xenobiotica. ج. 22 ع. 1: 1–11. DOI:10.3109/00498259209053097. PMID:1615700.
Dainippon Sumitomo Pharma Co. Ltd. (2005). "Company History". Company Information. Dainippon Sumitomo Co., Ltd. مؤرشف من الأصل في 2006-02-13. اطلع عليه بتاريخ 2005-11-12.
Iwata, Y؛ Irie, S؛ Uchida, H؛ Suzuki, T؛ Watanabe, K؛ Iwashita, S؛ Mimura, M (15 أبريل 2012). "Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial". Journal of the Neurological Sciences. ج. 315 ع. 1–2: 137–140. DOI:10.1016/j.jns.2011.12.010. PMID:22285275.
Gadde، Kishore M.؛ Franciscy، Deborah M.؛ Wagner, II، H. Ryan؛ Krishnan، K. Ranga R. (أبريل 2003). "Zonisamide for Weight Loss in Obese Adults: A Randomized Controlled Trial". Journal of the American Medical Association. ج. 289 ع. 14: 1820–1825. DOI:10.1001/jama.289.14.1820. PMID:12684361.
Hasegawa، Hisanori (مايو 2004). "utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital". Curr Med Research Opinion. ج. 20 ع. 5: 577–580. DOI:10.1185/030079904125003313. PMID:15140322.
Leppik، Ilo E. (ديسمبر 2004). "Zonisamide: chemistry, mechanism of action, and pharmacokinetics". Seizure. ج. 13 ع. Suppl 1: S5–9, discussion S10. DOI:10.1016/j.seizure.2004.04.016. PMID:15511691.
Mimaki، T؛ Suzuki، Y؛ Tagawa، T؛ Karasawa، T؛ Yabuuchi، H (مارس 1990). "Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain". Medical Journal of Osaka University. ج. 39 ع. 1–4: 13–7. PMID:1369646.
Mimaki، T؛ Suzuki، Y؛ Tagawa، T؛ Karasawa، T؛ Yabuuchi، H (مارس 1990). "[3H]zonisamide binding in rat brain". Medical Journal of Osaka University. ج. 39 ع. 1–4: 19–22. PMID:1369647.
Ueda، Y؛ Doi، T؛ Tokumaru، J؛ Willmore، J (19 أغسطس 2003). "Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures". Molecular Brain Research. ج. 116 ع. 1–2: 1–6. DOI:10.1016/S0169-328X(03)00183-9. PMID:12941455.
Ohmori، S.؛ Nakasa H؛ Asanome K؛ Kurose Y؛ Ishii I؛ Hosokawa M؛ Kitada M (8 مايو 1998). "Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells". Biochimica et Biophysica Acta. ج. 1380 ع. 3: 297–304. DOI:10.1016/s0304-4165(97)00156-6. PMID:9555064.
Stiff، D. D.؛ Robicheau JT؛ Zemaitis MA. (يناير 1992). "Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative". Xenobiotica. ج. 22 ع. 1: 1–11. DOI:10.3109/00498259209053097. PMID:1615700.
tga.gov.au
ebs.tga.gov.au
"Zonegran® Product Information". TGA eBusiness Services. SciGen (Australia) Pty Ltd. 4 أبريل 2013. مؤرشف من الأصل(PDF) في 2018-10-15. اطلع عليه بتاريخ 2013-11-18.
web.archive.org
"Zonegran® Product Information". TGA eBusiness Services. SciGen (Australia) Pty Ltd. 4 أبريل 2013. مؤرشف من الأصل(PDF) في 2018-10-15. اطلع عليه بتاريخ 2013-11-18.
Dainippon Sumitomo Pharma Co. Ltd. (2005). "Company History". Company Information. Dainippon Sumitomo Co., Ltd. مؤرشف من الأصل في 2006-02-13. اطلع عليه بتاريخ 2005-11-12.